BenevolentAI SPAC Presentation Deck

Investing in a premium platform at an attractive valuation Tech Approach In-house Clinical Pipeline In-house Platform- Derived In Clinic Big Pharma Discovery Collaborations Market Cap¹ Benevolent O RECURSION Knowledge Graph Mechanism- mapping 1 1 AstraZeneca €1.5bn² 1) As of 1 December 2021 2) Implied SPAC merger value, assuming no redemptions High throughput imaging 4 O B BAYER E $3.0bn RELAY THERAPEUTICS Protein Motion 2 BenevolentAl Proprietary 2 $3.1bn SCHRÖDINGER. Simulations -Physics based O O Bristol-Myers Squibb $2.6bn Exscientia Al-based drug design 1 SANOFI 1 Sumitomo Dainippon Pharma Bristol-Myers Squibb $2.6bn Benevolent 39

View entire presentation